Stock Market news at lse.co.uk - RSS News Feeds

Shire Share News (SHP)



Share News for Shire (SHP)


Share Price: 2,168.00Bid: 2,164.00Ask: 2,166.00Change: 0.00 (0.00%)No Movement on Shire
Spread: 2.00Spread as %: 0.09%Open: 2,139.00High: 2,174.00Low: 2,132.00Yesterday’s Close: 2,168.00






Shire ups its full-year sales guidance to 20 percent after strong Q2 UPDATE

(Recasts, adds CEO comment, detail) LONDON (Thomson Financial) - Shire Ltd. upped its guidance for 2008 revenue growth be at least 20 percen
[31 Jul '08]

Shire ups FY revenue guidance as Q2 sales rise 35 percent

LONDON (Thomson Financial) - Shire Ltd. upped its guidance for 2008 revenues to be at least 20 percent above year ago-levels as it delievered a
[31 Jul '08]

London shares outlook - higher after Wall St gains; HBOS, Shell numbers in focus

LONDON (Thomson Financial) - Leading shares are expected to open a touch firmer Thursday, building on Wall Street's gains overnight but with sen
[31 Jul '08]

Shire non-executive director Robin Buchanan to step down on July 29

LONDON (Thomson Financial) - Biopharmaceutical company Shire Limited said non-executive director Robin Buchanan will step down from the board of
[21 Jul '08]

Shire says EU approves Jerini's Firazyr

LONDON (Thomson Financial) - Jerini AG, which Shire Ltd. is buying for 328 million euros, has received approval from the European Commission to
[15 Jul '08]

Shire to acquire biotechnology company Jerini for 328 million euros UPDATE

(Adds analyst comment) LONDON (Thomson Financial) - Shire Plc., the specialty pharmaceutical company, is set to acquire Berlin-based biotech
[3 Jul '08]

Shire to acquire biotechnology company Jerini for 328 million euros UPDATE

(Adds CEO comment, detail throughout) LONDON (Thomson Financial) - Shire Plc., the specialty pharmaceutical company, is set to acquire Berli
[3 Jul '08]

Shire to acquire biotechnology company Jerini for 328 million euros

LONDON (Thomson Financial) - Shire Plc, the specialty pharmaceutical company, is set to acquire Berlin-based biotechnology company Jerini AG in
[3 Jul '08]



Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.